Major or mild neurocognitive disorder due to Parkinson's disease
|
Parkinson's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Major or mild neurocognitive disorder due to Parkinson's disease On the Web |
|
American Roentgen Ray Society Images of Major or mild neurocognitive disorder due to Parkinson's disease |
|
FDA on Major or mild neurocognitive disorder due to Parkinson's disease |
|
CDC on Major or mild neurocognitive disorder due to Parkinson's disease |
|
Major or mild neurocognitive disorder due to Parkinson's disease in the news |
|
Blogs on Major or mild neurocognitive disorder due to Parkinson's disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Overview
Major or Mild Neurocognitive Disorder Due to Parkinson's Disease
Epidemiology and Demographics
Prevalence
The prevalence of major or mild neurocognitive disorder due to parkinson's disease is:
75,000 per 100,000 (75%) major neurocognitive disorder.
27,000 per 100,000 (27%) mild neurocognitive disorder.[1]
Risk Factors
Risk factors for developing Cognitive impairment and dementia in Parkinson disease are: Duration of PD, severity of the disease, age of onset >60 years, old age, presence of rapid eye movement sleep behavior disorder, autonomic dysfunction, gait problem and hyposmia.[2][3][4][5][6][7][8][9][10]
Differential Diagnosis
the differential diagnosis for PDD includes:
- Dementia with Lewy bodies
- Multiple system atrophy
- Corticobasal degeneration
- Progressive supranuclear palsy.
- vascular parkinsonism
References
- ↑ Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
- ↑ Anang JB, Gagnon JF, Bertrand JA, Romenets SR, Latreille V, Panisset M, Montplaisir J, Postuma RB (September 2014). "Predictors of dementia in Parkinson disease: a prospective cohort study". Neurology. 83 (14): 1253–60. doi:10.1212/WNL.0000000000000842. PMC 4180482. PMID 25171928.
- ↑ Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM (January 2017). "Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study". Lancet Neurol. 16 (1): 66–75. doi:10.1016/S1474-4422(16)30328-3. PMC 5377592. PMID 27866858.
- ↑ Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RH, Spokes EG (April 2000). "A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease". Neurology. 54 (8): 1596–602. PMID 10762499.
- ↑ Reid WG, Hely MA, Morris JG, Broe GA, Adena M, Sullivan DJ, Williamson PM (October 1996). "A longitudinal of Parkinson's disease: clinical and neuropsychological correlates of dementia". J Clin Neurosci. 3 (4): 327–33. PMID 18638897.
- ↑ Stern Y, Marder K, Tang MX, Mayeux R (September 1993). "Antecedent clinical features associated with dementia in Parkinson's disease". Neurology. 43 (9): 1690–2. PMID 8414013.
- ↑ Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y (May 1992). "A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender". Arch. Neurol. 49 (5): 492–7. PMID 1580811.
- ↑ Hobson P, Meara J (September 2004). "Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom". Mov. Disord. 19 (9): 1043–9. doi:10.1002/mds.20216. PMID 15372593.
- ↑ Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sørensen P (March 2001). "Risk of dementia in Parkinson's disease: a community-based, prospective study". Neurology. 56 (6): 730–6. PMID 11274306.
- ↑ Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P (March 2003). "Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study". Arch. Neurol. 60 (3): 387–92. PMID 12633150.